<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Kılavuzlar</title><style>
/* cspell:disable-file */
/* webkit printing magic: print all background colors */
html {
	-webkit-print-color-adjust: exact;
}
* {
	box-sizing: border-box;
	-webkit-print-color-adjust: exact;
}

html,
body {
	margin: 0;
	padding: 0;
}
@media only screen {
	body {
		margin: 2em auto;
		max-width: 900px;
		color: rgb(55, 53, 47);
	}
}

body {
	line-height: 1.5;
	white-space: pre-wrap;
}

a,
a.visited {
	color: inherit;
	text-decoration: underline;
}

.pdf-relative-link-path {
	font-size: 80%;
	color: #444;
}

h1,
h2,
h3 {
	letter-spacing: -0.01em;
	line-height: 1.2;
	font-weight: 600;
	margin-bottom: 0;
}

.page-title {
	font-size: 2.5rem;
	font-weight: 700;
	margin-top: 0;
	margin-bottom: 0.75em;
}

h1 {
	font-size: 1.875rem;
	margin-top: 1.875rem;
}

h2 {
	font-size: 1.5rem;
	margin-top: 1.5rem;
}

h3 {
	font-size: 1.25rem;
	margin-top: 1.25rem;
}

.source {
	border: 1px solid #ddd;
	border-radius: 3px;
	padding: 1.5em;
	word-break: break-all;
}

.callout {
	border-radius: 10px;
	padding: 1rem;
}

figure {
	margin: 1.25em 0;
	page-break-inside: avoid;
}

figcaption {
	opacity: 0.5;
	font-size: 85%;
	margin-top: 0.5em;
}

mark {
	background-color: transparent;
}

.indented {
	padding-left: 1.5em;
}

hr {
	background: transparent;
	display: block;
	width: 100%;
	height: 1px;
	visibility: visible;
	border: none;
	border-bottom: 1px solid rgba(55, 53, 47, 0.09);
}

img {
	max-width: 100%;
}

@media only print {
	img {
		max-height: 100vh;
		object-fit: contain;
	}
}

@page {
	margin: 1in;
}

.collection-content {
	font-size: 0.875rem;
}

.collection-content td {
	white-space: pre-wrap;
	word-break: break-word;
}

.column-list {
	display: flex;
	justify-content: space-between;
}

.column {
	padding: 0 1em;
}

.column:first-child {
	padding-left: 0;
}

.column:last-child {
	padding-right: 0;
}

.table_of_contents-item {
	display: block;
	font-size: 0.875rem;
	line-height: 1.3;
	padding: 0.125rem;
}

.table_of_contents-indent-1 {
	margin-left: 1.5rem;
}

.table_of_contents-indent-2 {
	margin-left: 3rem;
}

.table_of_contents-indent-3 {
	margin-left: 4.5rem;
}

.table_of_contents-link {
	text-decoration: none;
	opacity: 0.7;
	border-bottom: 1px solid rgba(55, 53, 47, 0.18);
}

table,
th,
td {
	border: 1px solid rgba(55, 53, 47, 0.09);
	border-collapse: collapse;
}

table {
	border-left: none;
	border-right: none;
}

th,
td {
	font-weight: normal;
	padding: 0.25em 0.5em;
	line-height: 1.5;
	min-height: 1.5em;
	text-align: left;
}

th {
	color: rgba(55, 53, 47, 0.6);
}

ol,
ul {
	margin: 0;
	margin-block-start: 0.6em;
	margin-block-end: 0.6em;
}

li > ol:first-child,
li > ul:first-child {
	margin-block-start: 0.6em;
}

ul > li {
	list-style: disc;
}

ul.to-do-list {
	padding-inline-start: 0;
}

ul.to-do-list > li {
	list-style: none;
}

.to-do-children-checked {
	text-decoration: line-through;
	opacity: 0.375;
}

ul.toggle > li {
	list-style: none;
}

ul {
	padding-inline-start: 1.7em;
}

ul > li {
	padding-left: 0.1em;
}

ol {
	padding-inline-start: 1.6em;
}

ol > li {
	padding-left: 0.2em;
}

.mono ol {
	padding-inline-start: 2em;
}

.mono ol > li {
	text-indent: -0.4em;
}

.toggle {
	padding-inline-start: 0em;
	list-style-type: none;
}

/* Indent toggle children */
.toggle > li > details {
	padding-left: 1.7em;
}

.toggle > li > details > summary {
	margin-left: -1.1em;
}

.selected-value {
	display: inline-block;
	padding: 0 0.5em;
	background: rgba(206, 205, 202, 0.5);
	border-radius: 3px;
	margin-right: 0.5em;
	margin-top: 0.3em;
	margin-bottom: 0.3em;
	white-space: nowrap;
}

.collection-title {
	display: inline-block;
	margin-right: 1em;
}

.page-description {
	margin-bottom: 2em;
}

.simple-table {
	margin-top: 1em;
	font-size: 0.875rem;
	empty-cells: show;
}
.simple-table td {
	height: 29px;
	min-width: 120px;
}

.simple-table th {
	height: 29px;
	min-width: 120px;
}

.simple-table-header-color {
	background: rgb(247, 246, 243);
	color: black;
}
.simple-table-header {
	font-weight: 500;
}

time {
	opacity: 0.5;
}

.icon {
	display: inline-flex;
	align-items: center;
	justify-content: center;
	max-width: 1.2em;
	max-height: 1.2em;
	text-decoration: none;
	vertical-align: text-bottom;
	margin-right: 0.5em;
}

img.icon {
	border-radius: 3px;
}

.callout img.notion-static-icon {
	width: 1em;
	height: 1em;
}

.callout p {
	margin: 0;
}

.callout h1,
.callout h2,
.callout h3 {
	margin: 0 0 0.6rem;
}

.user-icon {
	width: 1.5em;
	height: 1.5em;
	border-radius: 100%;
	margin-right: 0.5rem;
}

.user-icon-inner {
	font-size: 0.8em;
}

.text-icon {
	border: 1px solid #000;
	text-align: center;
}

.page-cover-image {
	display: block;
	object-fit: cover;
	width: 100%;
	max-height: 30vh;
}

.page-header-icon {
	font-size: 3rem;
	margin-bottom: 1rem;
}

.page-header-icon-with-cover {
	margin-top: -0.72em;
	margin-left: 0.07em;
}

.page-header-icon img {
	border-radius: 3px;
}

.link-to-page {
	margin: 1em 0;
	padding: 0;
	border: none;
	font-weight: 500;
}

p > .user {
	opacity: 0.5;
}

td > .user,
td > time {
	white-space: nowrap;
}

input[type="checkbox"] {
	transform: scale(1.5);
	margin-right: 0.6em;
	vertical-align: middle;
}

p {
	margin-top: 0.5em;
	margin-bottom: 0.5em;
}

.image {
	border: none;
	margin: 1.5em 0;
	padding: 0;
	border-radius: 0;
	text-align: center;
}

.code,
code {
	background: rgba(135, 131, 120, 0.15);
	border-radius: 3px;
	padding: 0.2em 0.4em;
	border-radius: 3px;
	font-size: 85%;
	tab-size: 2;
}

code {
	color: #eb5757;
}

.code {
	padding: 1.5em 1em;
}

.code-wrap {
	white-space: pre-wrap;
	word-break: break-all;
}

.code > code {
	background: none;
	padding: 0;
	font-size: 100%;
	color: inherit;
}

blockquote {
	font-size: 1em;
	margin: 1em 0;
	padding-left: 1em;
	border-left: 3px solid rgb(55, 53, 47);
}

blockquote.quote-large {
	font-size: 1.25em;
}

.bookmark {
	text-decoration: none;
	max-height: 8em;
	padding: 0;
	display: flex;
	width: 100%;
	align-items: stretch;
}

.bookmark-title {
	font-size: 0.85em;
	overflow: hidden;
	text-overflow: ellipsis;
	height: 1.75em;
	white-space: nowrap;
}

.bookmark-text {
	display: flex;
	flex-direction: column;
}

.bookmark-info {
	flex: 4 1 180px;
	padding: 12px 14px 14px;
	display: flex;
	flex-direction: column;
	justify-content: space-between;
}

.bookmark-image {
	width: 33%;
	flex: 1 1 180px;
	display: block;
	position: relative;
	object-fit: cover;
	border-radius: 1px;
}

.bookmark-description {
	color: rgba(55, 53, 47, 0.6);
	font-size: 0.75em;
	overflow: hidden;
	max-height: 4.5em;
	word-break: break-word;
}

.bookmark-href {
	font-size: 0.75em;
	margin-top: 0.25em;
}

.sans { font-family: ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol"; }
.code { font-family: "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace; }
.serif { font-family: Lyon-Text, Georgia, ui-serif, serif; }
.mono { font-family: iawriter-mono, Nitti, Menlo, Courier, monospace; }
.pdf .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK JP'; }
.pdf:lang(zh-CN) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK SC'; }
.pdf:lang(zh-TW) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK TC'; }
.pdf:lang(ko-KR) .sans { font-family: Inter, ui-sans-serif, -apple-system, BlinkMacSystemFont, "Segoe UI Variable Display", "Segoe UI", Helvetica, "Apple Color Emoji", Arial, sans-serif, "Segoe UI Emoji", "Segoe UI Symbol", 'Twemoji', 'Noto Color Emoji', 'Noto Sans CJK KR'; }
.pdf .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK JP'; }
.pdf:lang(zh-CN) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC'; }
.pdf:lang(zh-TW) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK TC'; }
.pdf:lang(ko-KR) .code { font-family: Source Code Pro, "SFMono-Regular", Menlo, Consolas, "PT Mono", "Liberation Mono", Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK KR'; }
.pdf .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK JP'; }
.pdf:lang(zh-CN) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK SC'; }
.pdf:lang(zh-TW) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK TC'; }
.pdf:lang(ko-KR) .serif { font-family: PT Serif, Lyon-Text, Georgia, ui-serif, serif, 'Twemoji', 'Noto Color Emoji', 'Noto Serif CJK KR'; }
.pdf .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK JP'; }
.pdf:lang(zh-CN) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK SC'; }
.pdf:lang(zh-TW) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK TC'; }
.pdf:lang(ko-KR) .mono { font-family: PT Mono, iawriter-mono, Nitti, Menlo, Courier, monospace, 'Twemoji', 'Noto Color Emoji', 'Noto Sans Mono CJK KR'; }
.highlight-default {
	color: rgba(44, 44, 43, 1);
}
.highlight-gray {
	color: rgba(125, 122, 117, 1);
	fill: rgba(125, 122, 117, 1);
}
.highlight-brown {
	color: rgba(159, 118, 90, 1);
	fill: rgba(159, 118, 90, 1);
}
.highlight-orange {
	color: rgba(210, 123, 45, 1);
	fill: rgba(210, 123, 45, 1);
}
.highlight-yellow {
	color: rgba(203, 148, 52, 1);
	fill: rgba(203, 148, 52, 1);
}
.highlight-teal {
	color: rgba(80, 148, 110, 1);
	fill: rgba(80, 148, 110, 1);
}
.highlight-blue {
	color: rgba(56, 125, 201, 1);
	fill: rgba(56, 125, 201, 1);
}
.highlight-purple {
	color: rgba(154, 107, 180, 1);
	fill: rgba(154, 107, 180, 1);
}
.highlight-pink {
	color: rgba(193, 76, 138, 1);
	fill: rgba(193, 76, 138, 1);
}
.highlight-red {
	color: rgba(207, 81, 72, 1);
	fill: rgba(207, 81, 72, 1);
}
.highlight-default_background {
	color: rgba(44, 44, 43, 1);
}
.highlight-gray_background {
	background: rgba(42, 28, 0, 0.07);
}
.highlight-brown_background {
	background: rgba(139, 46, 0, 0.086);
}
.highlight-orange_background {
	background: rgba(224, 101, 1, 0.129);
}
.highlight-yellow_background {
	background: rgba(211, 168, 0, 0.137);
}
.highlight-teal_background {
	background: rgba(0, 100, 45, 0.09);
}
.highlight-blue_background {
	background: rgba(0, 124, 215, 0.094);
}
.highlight-purple_background {
	background: rgba(102, 0, 178, 0.078);
}
.highlight-pink_background {
	background: rgba(197, 0, 93, 0.086);
}
.highlight-red_background {
	background: rgba(223, 22, 0, 0.094);
}
.block-color-default {
	color: inherit;
	fill: inherit;
}
.block-color-gray {
	color: rgba(125, 122, 117, 1);
	fill: rgba(125, 122, 117, 1);
}
.block-color-brown {
	color: rgba(159, 118, 90, 1);
	fill: rgba(159, 118, 90, 1);
}
.block-color-orange {
	color: rgba(210, 123, 45, 1);
	fill: rgba(210, 123, 45, 1);
}
.block-color-yellow {
	color: rgba(203, 148, 52, 1);
	fill: rgba(203, 148, 52, 1);
}
.block-color-teal {
	color: rgba(80, 148, 110, 1);
	fill: rgba(80, 148, 110, 1);
}
.block-color-blue {
	color: rgba(56, 125, 201, 1);
	fill: rgba(56, 125, 201, 1);
}
.block-color-purple {
	color: rgba(154, 107, 180, 1);
	fill: rgba(154, 107, 180, 1);
}
.block-color-pink {
	color: rgba(193, 76, 138, 1);
	fill: rgba(193, 76, 138, 1);
}
.block-color-red {
	color: rgba(207, 81, 72, 1);
	fill: rgba(207, 81, 72, 1);
}
.block-color-default_background {
	color: inherit;
	fill: inherit;
}
.block-color-gray_background {
	background: rgba(240, 239, 237, 1);
}
.block-color-brown_background {
	background: rgba(245, 237, 233, 1);
}
.block-color-orange_background {
	background: rgba(251, 235, 222, 1);
}
.block-color-yellow_background {
	background: rgba(249, 243, 220, 1);
}
.block-color-teal_background {
	background: rgba(232, 241, 236, 1);
}
.block-color-blue_background {
	background: rgba(229, 242, 252, 1);
}
.block-color-purple_background {
	background: rgba(243, 235, 249, 1);
}
.block-color-pink_background {
	background: rgba(250, 233, 241, 1);
}
.block-color-red_background {
	background: rgba(252, 233, 231, 1);
}
.select-value-color-default { background-color: rgba(42, 28, 0, 0.07); }
.select-value-color-gray { background-color: rgba(28, 19, 1, 0.11); }
.select-value-color-brown { background-color: rgba(127, 51, 0, 0.156); }
.select-value-color-orange { background-color: rgba(196, 88, 0, 0.203); }
.select-value-color-yellow { background-color: rgba(209, 156, 0, 0.282); }
.select-value-color-green { background-color: rgba(0, 96, 38, 0.156); }
.select-value-color-blue { background-color: rgba(0, 118, 217, 0.203); }
.select-value-color-purple { background-color: rgba(92, 0, 163, 0.141); }
.select-value-color-pink { background-color: rgba(183, 0, 78, 0.152); }
.select-value-color-red { background-color: rgba(206, 24, 0, 0.164); }

.checkbox {
	display: inline-flex;
	vertical-align: text-bottom;
	width: 16;
	height: 16;
	background-size: 16px;
	margin-left: 2px;
	margin-right: 5px;
}

.checkbox-on {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20width%3D%2216%22%20height%3D%2216%22%20fill%3D%22%2358A9D7%22%2F%3E%0A%3Cpath%20d%3D%22M6.71429%2012.2852L14%204.9995L12.7143%203.71436L6.71429%209.71378L3.28571%206.2831L2%207.57092L6.71429%2012.2852Z%22%20fill%3D%22white%22%2F%3E%0A%3C%2Fsvg%3E");
}

.checkbox-off {
	background-image: url("data:image/svg+xml;charset=UTF-8,%3Csvg%20width%3D%2216%22%20height%3D%2216%22%20viewBox%3D%220%200%2016%2016%22%20fill%3D%22none%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%0A%3Crect%20x%3D%220.75%22%20y%3D%220.75%22%20width%3D%2214.5%22%20height%3D%2214.5%22%20fill%3D%22white%22%20stroke%3D%22%2336352F%22%20stroke-width%3D%221.5%22%2F%3E%0A%3C%2Fsvg%3E");
}
	
</style></head><body><article id="07f20785-9ae8-4d3d-befb-25f654db3c79" class="page sans"><header><h1 class="page-title">Kılavuzlar</h1><p class="page-description"></p></header><div class="page-body"><h1 id="d6010c3e-7d3b-47b5-abba-8d6085a7f282" class="">HPLC Yöntem Validasyonu: Referanslar Listesi</h1><p id="127b6792-444f-8064-b0e5-faf83491b230" class="">
</p><p id="127b6792-444f-8093-8aef-ce0e92fa3443" class="">Not: Tüm referanslar için en güncel versiyonları kontrol etmek önemlidir, çünkü rehberler ve standartlar zaman zaman güncellenmektedir. Ayrıca, bazı kaynaklar abonelik veya satın alma gerektirebilir.</p><h2 id="20339f91-fdcf-4d1c-a121-eb14cebfa40d" class="">Uluslararası Kılavuzlar</h2><ol type="1" id="66a107d6-7371-423e-a9cd-7a7bf0e46af1" class="numbered-list" start="1"><li>ICH Q2(R1) (2005). Validation of Analytical Procedures: Text and Methodology.<br/><a href="https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf">https://database.ich.org/sites/default/files/Q2(R1) Guideline.pdf</a><figure id="e1a42ce9-04d2-4c42-89a2-7d006dac3a79"><div class="source"><a href="guidelines/Q2(R1)_Guideline.pdf">Q2(R1) Guideline.pdf</a></div></figure></li></ol><ol type="1" id="f0c3e11a-c610-4ce4-9193-ce1109648ec3" class="numbered-list" start="2"><li>ICH Q7 (2000). Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.<br/><a href="https://database.ich.org/sites/default/files/Q7%20Guideline.pdf">https://database.ich.org/sites/default/files/Q7 Guideline.pdf</a><figure id="83f40dd4-2742-4760-8ac9-ce28f22211ee"><div class="source"><a href="guidelines/Q7_Guideline.pdf">Q7 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="bc0557a1-d36b-434c-b3fc-5ab8589b4b03" class="numbered-list" start="3"><li>ICH Q8(R2) (2009). Pharmaceutical Development.<br/><a href="https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf">https://database.ich.org/sites/default/files/Q8(R2) Guideline.pdf</a><figure id="9f7dcfda-6e52-49ab-bc5b-e9d115aa3130"><div class="source"><a href="guidelines/Q8(R2)_Guideline_(1).pdf">Q8(R2) Guideline.pdf</a></div></figure></li></ol><ol type="1" id="358bfa81-c971-4932-885b-96d6d14ce570" class="numbered-list" start="4"><li>ICH Q9 (2005). Quality Risk Management.<br/><a href="https://database.ich.org/sites/default/files/Q9%20Guideline.pdf">https://database.ich.org/sites/default/files/Q9 Guideline.pdf</a><figure id="3bb61047-25a0-4d8f-947a-0450a7fa8e81"><div class="source"><a href="guidelines/Q9_Guideline.pdf">Q9 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="683c865e-3a83-4179-bb50-a3e735a4455e" class="numbered-list" start="5"><li>ICH Q10 (2008). Pharmaceutical Quality System.<br/><a href="https://database.ich.org/sites/default/files/Q10%20Guideline.pdf">https://database.ich.org/sites/default/files/Q10 Guideline.pdf</a><figure id="24ff48f3-93c1-42b6-b0c4-5ef216e0a09a"><div class="source"><a href="guidelines/Q10_Guideline.pdf">Q10 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="33587755-0db2-4cf0-ba2f-8adbc7df3c14" class="numbered-list" start="6"><li>ICH Q11 (2012). Development and Manufacture of Drug Substances.<br/><a href="https://database.ich.org/sites/default/files/Q11%20Guideline.pdf">https://database.ich.org/sites/default/files/Q11 Guideline.pdf</a><figure id="dcef1b15-34a2-4082-adff-b3c43d8e2d73"><div class="source"><a href="guidelines/Q11_Guideline.pdf">Q11 Guideline.pdf</a></div></figure></li></ol><h2 id="fc2f45a7-c1a7-43f9-bb3f-fcedc94ebbd9" class="">Farmakopeler</h2><ol type="1" id="004504e0-d2c8-4d4b-8348-82ad02fcdf93" class="numbered-list" start="1"><li>United States Pharmacopeia (USP) &lt;1225&gt;: Validation of Compendial Procedures.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.usp.org/">https://www.usp.org/</a>)</li></ol><ol type="1" id="e655d7f4-f779-420b-aeda-6f7d08e06160" class="numbered-list" start="2"><li>European Pharmacopoeia (EP) 2.2.46: Chromatographic Separation Techniques.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition">https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition</a>)</li></ol><ol type="1" id="b0f48dc8-7dc7-479e-b1aa-9a04d968d085" class="numbered-list" start="3"><li>Japanese Pharmacopoeia (JP) G1: Validation of Analytical Procedures.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066530.html">https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066530.html</a>)</li></ol><h2 id="9069d824-fe51-4b56-bfca-dde4b5105319" class="">FDA Rehberleri</h2><ol type="1" id="f4063ab9-b97c-4cbf-b424-7f0c4853cc1a" class="numbered-list" start="1"><li>FDA (2015). Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry.<br/><a href="https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf">https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf</a><figure id="d24e53a7-de15-4b4c-a820-0fb206ff2205"><div class="source"><a href="guidelines/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf">Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf</a></div></figure></li></ol><ol type="1" id="3a136c8c-ec53-4629-b30c-07ba83954ef1" class="numbered-list" start="2"><li>FDA (2018). Data Integrity and Compliance With Drug CGMP: Questions and Answers Guidance for Industry.<br/><a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers-guidance-industry">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers-guidance-industry</a><figure id="0fbb6792-444f-80c0-81e9-eb6628e2b1a9"><div class="source"><a href="guidelines/Data_Integrity_and_Compliance.pdf">Data Integrity and Compliance.pdf</a></div></figure></li></ol><ol type="1" id="05a72785-0d1f-494d-929b-485ce1e4a1d5" class="numbered-list" start="3"><li>FDA (2003). Part 11, Electronic Records; Electronic Signatures - Scope and Application.<br/><a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application</a><figure id="4bd1c748-831e-4615-b1ea-4ca307b2f78b"><div class="source"><a href="guidelines/Guidance_for_Industry.pdf">Guidance for Industry.pdf</a></div></figure></li></ol><h2 id="e3742018-d786-41c4-ae2b-5f03a804d2b7" class="">EMA Rehberleri</h2><ol type="1" id="6fa7bdf5-fd25-4eb2-bd6a-50b74220b0fc" class="numbered-list" start="1"><li>EMA (2011). Guideline on bioanalytical method validation.<br/><a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf">https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf</a><figure id="75b55cad-f371-4bbf-9aa9-f7dec819cec4"><div class="source"><a href="guidelines/guideline-bioanalytical-method-validation_en.pdf">guideline-bioanalytical-method-validation_en.pdf</a></div></figure></li></ol><ol type="1" id="71246877-9def-4d35-a4b4-f15319dade18" class="numbered-list" start="2"><li>EudraLex Volume 4, Annex 11: Computerised Systems.<br/><a href="https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf">https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf</a><figure id="ce5165d3-f1b0-4bb6-b91f-839021250990"><div class="source"><a href="guidelines/EudraLex_Volume_4.pdf">EudraLex Volume 4.pdf</a></div></figure></li></ol><h2 id="2d232673-30a4-4c89-93f0-da0538d69f6f" class="">WHO Rehberleri</h2><ol type="1" id="e705638c-6a54-4027-aa06-a8910eab13f5" class="numbered-list" start="1"><li>WHO (2016). Guidance on Good Data and Record Management Practices.<br/><a href="https://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_annex05.pdf">https://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_annex05.pdf</a><figure id="0bc88dc9-7c44-4713-94d6-155cc8e7b57f"><div class="source"><a href="guidelines/Guidance_on_good_data_and_record_management_practices.pdf">Guidance on good data and record management practices.pdf</a></div></figure></li></ol><h2 id="d1127844-2862-46c3-89df-5c430e14e62f" class="">Diğer Düzenleyici Otoritelerin Rehberleri</h2><ol type="1" id="d7953f80-4108-4042-b2c6-0099418705c0" class="numbered-list" start="1"><li>MHRA (2018). &#x27;GXP&#x27; Data Integrity Guidance and Definitions.<br/><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf</a></li></ol><ol type="1" id="a1fb325c-e3e0-4043-ba41-d8ee0b2ade30" class="numbered-list" start="2"><li>PIC/S (2021). Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments.<br/><a href="https://picscheme.org/docview/4234">https://picscheme.org/docview/4234</a><figure id="dbceee3f-32d5-46e8-ac36-e90e9b295085"><div class="source"><a href="guidelines/Good_Practices_for_Data_Management_and_Integrity_in_Regulated_GMPGDP_Environments.pdf">Good Practices for Data Management and Integrity in Regulated GMPGDP Environments.pdf</a></div></figure></li></ol><h2 id="9382e810-ee9d-432f-8ca9-ea10c60f8401" class="">Bilimsel Makaleler ve Kitaplar</h2><ol type="1" id="43f85cfa-0dbf-4301-8aae-8a377a3247a7" class="numbered-list" start="1"><li>Snyder, L.R., Kirkland, J.J., &amp; Dolan, J.W. (2010). Introduction to Modern Liquid Chromatography (3rd ed.). John Wiley &amp; Sons.<figure id="3db62176-929e-4d38-93e2-b5496b4365fe"><div class="source"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf">MHRA_GxP_data_integrity_guide_March_edited_Final.pdf</a></div></figure></li></ol><ol type="1" id="1da67afb-a887-480e-982d-38f86fec6efb" class="numbered-list" start="2"><li>Ermer, J., &amp; Miller, J.H.M. (Eds.). (2005). Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. Wiley-VCH.<figure id="c86b1229-3242-4d4a-910d-f56c6f25f8c7"><div class="source"><a href="https://www.wellesu.com/10.1002/3527604685">Method Validation in Pharmaceutical Analysis</a></div></figure></li></ol><ol type="1" id="80a5c93d-91d9-463b-8fcc-1ed0c138901a" class="numbered-list" start="3"><li>habir, G.A. (2003). Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. Journal of Chromatography A, 987(1-2), 57-66.<figure id="1437ec59-fdba-4c62-90f1-befe027120a7"><div class="source"><a href="guidelines/Validation_of_high-performance_liquid_chromatography_methods_for_pharmaceutical_analysis.pdf">Validation of high-performance liquid chromatography methods for pharmaceutical analysis.pdf</a></div></figure></li></ol><p id="f1d85163-862c-4b9f-aa1a-4c2709e608c8" class="">
</p><p id="a7c02b46-fefa-4a80-83a3-4dd9d5132569" class="">
</p></div></article><span class="sans" style="font-size:14px;padding-top:2em"></span></body></html>